# Abogen Biosciences: Research, Wuxi, China

> Abogen Biosciences: Abogen Biosciences is a clinical-stage biotechnology company focused on RNA-based medicines, particularly in mRNA science and technology.

Source: https://millionrounds.com/startup/abogen-biosciences (Millionrounds; every figure on the page links to its filing or article)

China · [Research startup](https://millionrounds.com/companies)

# Abogen Biosciences

Abogen Biosciences is a clinical-stage biotechnology company focused on RNA-based medicines, particularly in mRNA science and technology.

Funding reported Last round: Venture (Round not Specified)

Research Wuxi, China

Company summary

- **Founded:** 2019 7 years old
- **Team:** 110 51 to 200 people
- **Funding reported:** 1.4B as listed, currency not stated
- **Last round:** Venture (Round not Specified) Dec 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Abogen Biosciences has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Abogen Biosciences

Abogen Biosciences is a clinical-stage biotechnology company focused on RNA-based medicines, particularly in mRNA science and technology.

The company aims to develop transformative therapies and vaccines to address untreatable diseases. It operates under the name Suzhou Abogen Biosciences Co., Ltd., with offices located in Suzhou, Shanghai, and Beijing. Abogen has integrated in-house technologies that support the full development cycle of mRNA medicines, including target selection, mRNA optimization, GMP production, and clinical delivery. Its pipeline includes candidates targeting varicella zoster virus (VZV), respiratory syncytial virus (RSV), and tuberculosis (TB).

## What company datasets say Abogen Biosciences raised

Funding, as reported

Reported in all **1.4B** in the source's currency

Last round **Venture (Round not Specified)**

Last round size **300M**

Last round date **Dec 2024**

## Founders and team

From Abogen Biosciences's own website: 1 founder, 7 on the team.

**Bo Ying** Founder, Chairman and CEO

- **Xiaotao Wang** Vice President of Platform Biology
- **Xinpeng Ma** Senior Vice President of Chemistry
- **Zhiyi Zhang** Vice President of Formulation R&D
- **Iain McFadyen** Chief AI Officer
- **Peng Gao** Chief Technology Officer
- **Wenjie Song** Chief Medical Officer
- **Ziyi Song** Chief Financial Officer

## On 3 portfolio pages

Investors who name them

- [Qiming Venture Partners](https://millionrounds.com/fund/qiming-venture-partners)
- [5Y Capital](https://millionrounds.com/fund/5y-capital)
- [Jifeng Ventures](https://millionrounds.com/fund/jifeng-ventures)

Each firm lists Abogen Biosciences on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

patented lipid formulations b2b protein engineering hospital & health care healthcare equipment & supplies health care oncology self-amplifying rna (sarna) proprietary technology scalable manufacturing ai-driven drug design cancer immunotherapy medical ai-enhanced rna design vaccine development biotechnology research

Built with from their website

Wagtail CMS aThemes Moesia eDirectory LOU R SAP Secured MVC Forum on Windows 2012 R2 HPLC Slim SEO SentenceTransformers

+8 more

Microsoft Advanced Group Policy Management Autoclave ANS Graphy Fortinet Mode Xtra Homestead

- **Sector:** Research
- **Industry code:** NAICS 541714, 325414, SIC 2834, 2836
- **Revenue:** 4.5M a year, as listed

## Research in China

Startups like it

- [**CMAB Biopharma** Suzhou · founded 2017 *Raised*](https://millionrounds.com/company/cmab-biopharma)
- [**HaploX Biotechnology** Shenzhen Shi · founded 2014 *Raised*](https://millionrounds.com/company/haplox-biotechnology)
- [**TriArm Therapeutics** founded 2018 *Raised*](https://millionrounds.com/company/triarm-therapeutics)
- [**Cure Genetics** Suzhou · founded 2016 *Raised*](https://millionrounds.com/company/curegenetics)
- [**BGI Group** Shenzhen Shi · founded 1999](https://millionrounds.com/startup/bgi-group)
- [**Baiming Xinkang Biotechnology (Hangzhou) Co., Ltd. Worgpharma)** Hang Zhou Shi · founded 2018](https://millionrounds.com/startup/baiming-xinkang-biotechnology-hangzhou-co-ltd-worgpharma)
- [**Chengdu Qitan Technology Co., Ltd.** Beijing · founded 2016](https://millionrounds.com/startup/chengdu-qitan-technology-co-ltd)
- [**Hangzhou DAC Biotech Co., Ltd.** Hangzhou · founded 2012](https://millionrounds.com/startup/hangzhou-dac-biotech-co-ltd)

## Is this your company?

Add your raise, your deck and your story, and put Abogen Biosciences in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)